This revised application is designed to continue and expand the training program in mental retardation and developmental disabilities (MRDD) at Mount Sinai School of Medicine. This program has been developed to provide a combined basic science and clinical background in the etiology, pathophysiology, prevention, and treatment of genetic diseases leading to MRDD. The training is primarily in the fields of genetics and neurobiology as related to MRDD. The specific subdisciplines include molecular and biochemical genetics, developmental neurobiology, neurogenetics, cytogenetics, and clinical genetics. Three major research themes of this program are: 1) elucidation of the basic molecular etiologies of genetic disorders resulting in MRDD, 2) application of molecular genetic and cell biologic techniques to investigate the basic biology and pathogenesis of these disorders, and 3) development and evaluation of molecular-based therapies for inherited diseases. There is interdisciplinary input which has been enhanced by the addition of outstanding faculty in molecular biology, neurobiology, cell biology, bioinformatics, and gene therapy, areas of recent institutional growth and expansion. Postdoctoral Ph.D. trainees will be primarily involved in research, while those with M.D. degrees also will participate in a clinical training component designed for exposure and experience in the diagnosis, management, and treatment of patients with MRDD of diverse etiologies. Predoctoral trainees will receive didactic training in human genetics, molecular/cellular biology, neurobiology, and mental retardation. Emphasis will be placed on rigorous research training with thesis dissertations in human genetics focused on specific problems in MRDD. All trainees will attend an annual retreat designed to provide a broad overview of MRDD and to highlight the latest advances, particularly as related to their genetic etiology, prevention, and treatment. All trainees also will attend the MRDD monthly seminar series. Highly qualified trainees will be selected from a national pool and special emphasis will be directed to recruit women and underrepresented minorities. Internal and External Advisory Committees will review progress and advise the Program Directors on new directions and programmatic, trainee, and administrative issues. In addition, the proposed program will imbue trainees with the principles of integrity in the conduct of research. It is anticipated that these trainees will continue the tradition of this program by becoming basic and/or clinical researchers in the field of human genetics and mental retardation. ? ?

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Institutional National Research Service Award (T32)
Project #
2T32HD007105-26A1
Application #
6592727
Study Section
Pediatrics Subcommittee (CHHD)
Program Officer
Oster-Granite, Mary Lou
Project Start
1977-07-15
Project End
2008-04-30
Budget Start
2003-07-07
Budget End
2004-04-30
Support Year
26
Fiscal Year
2003
Total Cost
$313,069
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Genetics
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Bard, Kim A; Brent, Linda; Lester, Barry et al. (2011) Neurobehavioral Integrity of Chimpanzee Newborns: Comparisons across groups and across species reveal gene-environment interaction effects. Infant Child Dev 20:47-93
Mc Guire, Peter J; Lim-Melia, Elizabeth; Diaz, George A et al. (2008) Combined liver-kidney transplant for the management of methylmalonic aciduria: a case report and review of the literature. Mol Genet Metab 93:22-9
Yasuda, Makiko; Domaradzki, Maciej E; Armentano, Donna et al. (2007) Acute intermittent porphyria: vector optimization for gene therapy. J Gene Med 9:806-11
Bishop, David F; Johansson, Annika; Phelps, Robert et al. (2006) Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions. Am J Hum Genet 78:645-58
Shabbeer, Junaid; Yasuda, Makiko; Benson, Stacy D et al. (2006) Fabry disease: identification of 50 novel alpha-galactosidase A mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations. Hum Genomics 2:297-309
Tukel, T; Uzumcu, A; Gezer, A et al. (2005) A new syndrome, congenital extraocular muscle fibrosis with ulnar hand anomalies, maps to chromosome 21qter. J Med Genet 42:408-15
Yoon-Robarts, Miran; Linden, R Michael (2003) Identification of active site residues of the adeno-associated virus type 2 Rep endonuclease. J Biol Chem 278:4912-8
Levy, Brynn; Dunn, Teresa M; Kern, Jeffrey H et al. (2002) Delineation of the dup5q phenotype by molecular cytogenetic analysis in a patient with dup5q/del 5p (cri du chat). Am J Med Genet 108:192-7
Tadin, M; Braverman, E; Cianfarani, S et al. (2001) Complex cytogenetic rearrangement of chromosome 8q in a case of Ambras syndrome. Am J Med Genet 102:100-4
Amma, L L; Campos-Barros, A; Wang, Z et al. (2001) Distinct tissue-specific roles for thyroid hormone receptors beta and alpha1 in regulation of type 1 deiodinase expression. Mol Endocrinol 15:467-75

Showing the most recent 10 out of 40 publications